AWM
INSM icon

Able Wealth Management’s Insmed INSM Stock Holding History

Able Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18
Closed -$558 – 320
2023
Q4 		$558 Buy
+18
New +$467 ﹤0.01% 549

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Able Wealth Management's INSM Position: Q1 2024 in Review

Able Wealth Management sold out of Insmed (INSM) in Q1 2024, closing a stake of 18 shares — an estimated $558 sold.

Able Wealth Management first reported a position in INSM in Q4 2023 and held it in 1 quarter. The position peaked at $558 in Q4 2023. 288 funds tracked by Wall St. Rank hold INSM as of Q1 2024.

  • Able Wealth Management reported no remaining Insmed position as of Q1 2024 after selling out during the quarter.
  • Able Wealth Management sold 18 Insmed shares in Q1 2024, an estimated $558.
  • Able Wealth Management first reported a position in Insmed in Q4 2023 and held it in 1 quarter.
  • Able Wealth Management's Insmed position peaked at $558 in Q4 2023.
  • 288 funds tracked by Wall St. Rank held Insmed as of Q1 2024.

Based on Able Wealth Management's 13F filing for Q1 2024, filed 1 Nov 2024.